Zobrazeno 1 - 10 of 252 pro vyhledávání: '"Stuart GCE"'
1
Report
Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?
Autor: Barnes D; Department of Obstetrics and Gynecology, University of British Columbia, Canada., Mohammad N; Department of Pathology, Vancouver General Hospital and the University of British Columbia, Canada., Hoang L; Department of Pathology, Vancouver General Hospital and the University of British Columbia, Canada., Anglesio M; Department of Obstetrics and Gynecology, University of British Columbia, Canada., Hollis RL; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, MRC Institute of Genetics and Cancer, University of Edinburgh, UK., Gourley C; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, MRC Institute of Genetics and Cancer, University of Edinburgh, UK., Stuart HC; Department of Surgery, Vancouver General Hospital, and the University of British Columbia, Canada., Carey MS; Department of Obstetrics and Gynecology, University of British Columbia, Canada., Stuart GCE; Department of Obstetrics and Gynecology, University of British Columbia, Canada.
Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2022 Oct 14; Vol. 44, pp. 101076. Date of Electronic Publication: 2022 Oct 14 (Print Publication: 2022).
Zobrazit plný text záznamu
2
Akademický článek
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Autor: Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Gonzalez-Martin A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Madrid, and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain., Lorusso D; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy; Fondazione Policlinico Gemelli IRCCS, Rome, Italy., Gourley C; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Mirza MR; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark., Kurtz JE; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Strasbourg Cancer Institute, Strasbourg, France., Okamoto A; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan; The Jikei University School of Medicine, Tokyo, Japan., Moore K; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; OU Health Stephenson Cancer Center, Oklahoma City, OH, USA., Kridelka F; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Centre Hospitalier Universitaire de Liège, Liège, Belgium., McNeish I; National Cancer Research Institute (NCRI), London, UK; Department of Surgery and Cancer, Imperial College London, London, UK., Reuss A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Coordinating Center for Clinical Trials, Philipps University, Marburg, Germany., Votan B; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, Paris, France., du Bois A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Kliniken Essen Mitte (KEM), Essen, Germany., Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; University Hospital, Ludwig Maximilians University, Munich, Germany., Ray-Coquard I; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France., Kohn EC; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berek JS; Women's Cancer Research Network-Cooperative Gynecologic Oncology Investigators (WCRN-COGI), Fresno, CA; Stanford Cancer Institute, Stanford, CA, USA., Tan DSP; Asia Pacific Gynecologic Oncology Trials Group (APGOT), Seoul, South Korea; Gynecologic Cancer Group Singapore (GCGS), Singapore; Cancer Science Institute, National University of Singapore, Singapore., Colombo N; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy; European Institute of Oncology, Milan, Italy; University of Milano-Bicocca, Milan, Italy., Zang R; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China; Zhongshan Hospital, Fudan University, Shanghai, China., Concin N; AGO -Austria, Innsbruck, Austria; Kliniken Essen Mitte (KEM), Essen, Germany; Medical University of Innsbruck, Innsbruck, Austria., O'Donnell D; Cancer Trials Ireland (CTI), Dublin, Ireland; St James's Hospital, Dublin, Ireland., Rauh-Hain A; Global Gynecologic Oncology Consortium (G-GOC), Houston, TX, USA; MD Anderson Cancer Center, The University of Texas, Houston, TX, USA., Herrington CS; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Marth C; AGO -Austria, Innsbruck, Austria; Medical University of Innsbruck, Innsbruck, Austria., Poveda A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Hospital Quironsalud, Valencia, Spain., Fujiwara K; Gynecologic Cancer Clinical Trials and Investigation Consortium (GOTIC), North Kanto, Japan; Saitama Medical University International Medical Center, Saitama, Japan., Stuart GCE; Canadian Cancer Trials Group (CCTG), Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada., Oza AM; Princess Margaret Hospital Consortium (PMHC), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bookman MA; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; San Francisco Medical Center, San Francisco, CA, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. e374-e384.
Zobrazit plný text záznamu
3
Akademický článek
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.
Autor: Coldman AJ; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., van Niekerk D; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada., Krajden M; BC Centre for Disease Control, Vancouver, BC, Canada., Smith LW; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., Cook D; BC Centre for Disease Control, Vancouver, BC, Canada., Gondara L; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., Ceballos K; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada., Quinlan DJ; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Lee M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Elwood-Martin R; School of Public Health, University of British Columbia, Vancouver, BC, Canada., Gentile L; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada., Peacock S; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, BC, Canada., Stuart GCE; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Franco EL; Division of Cancer Epidemiology, McGill University, Montreal, QC, Canada., Ogilvie GS; Women's Health Research Institute, Vancouver, BC, Canada.
Publikováno v: International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1810-1818. Date of Electronic Publication: 2019 Jul 04.
Zobrazit plný text záznamu
4
Akademický článek
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Autor: Ogilvie GS; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada., van Niekerk D; Lower Mainland Laboratories, Vancouver, British Columbia, Canada.; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Krajden M; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada., Smith LW; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Cook D; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Gondara L; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Ceballos K; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Quinlan D; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lee M; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Martin RE; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Gentile L; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada., Peacock S; Cancer Control Research, BC Cancer, British Columbia, Canada.; Canadian Centre for Applied Research in Cancer Control, Vancouver, British Columbia, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada., Stuart GCE; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Franco EL; Departments of Oncology and Epidemiology & Biostatistics, McGill University, Montreal, Quebec, Canada., Coldman AJ; Cervical Cancer Screening Program, British Columbia Cancer, Vancouver, British Columbia, Canada.
Publikováno v: JAMA [JAMA] 2018 Jul 03; Vol. 320 (1), pp. 43-52.
Zobrazit plný text záznamu
5
Akademický článek
FT-Raman and FTIR spectroscopy as a tools showing marker of platinum-resistant phenomena in women suffering from ovarian cancer.
Autor: Kluz-Barłowska, Marta1 (AUTHOR) marta.kluz@interia.pl, Kluz, Tomasz2,3 (AUTHOR), Paja, Wiesław4 (AUTHOR), Pancerz, Krzysztof5 (AUTHOR), Łączyńska-Madera, Monika2 (AUTHOR), Miziak, Paulina6 (AUTHOR), Cebulski, Jozef7 (AUTHOR), Depciuch, Joanna6,8 (AUTHOR) joanna.depciuch@ifj.edu.pl
Publikováno v: Scientific Reports. 5/14/2024, Vol. 14 Issue 1, p1-11. 11p.
Zobrazit plný text záznamu
6
Akademický článek
The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.
Autor: Stuart GCE; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario, Canada., Kitchener HC, Vermorken JB, Quinn MJ, Small W Jr, Pujade-Lauraine E, Chou H, Wong M, Bacon M
Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2017 May; Vol. 27 (4), pp. 813-818.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje